Safety And PK Study Of CVX-060 In Patients With Advanced Solid Tumors

Completed · Phase 1

Conditions studied: Advanced Solid Tumors, Neoplasms, Carcinoma, Cancer, Malignancy

In brief

The purpose of this study is to determine the safety and tolerability of CVX-060 in patients with advanced solid tumors.

Key facts

Study ID

NCT00879684

Run by

Pfizer

People needed

34

Starts

2008-01-01

Expected to finish

2011-04-01

Last updated by the study team

2015-01-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Confirmed advanced solid tumors unresponsive to currently available therapies or for which there is no standard therapy.
• Adequate coagulation, liver, and renal function.
• Candidate for DCE-MRI evaluations.
• ECOG (Eastern Cooperative Oncology Group) performance status of 0 or 1.

You may not qualify if…

• Evidence of significant bleeding problems.
• History of certain gastrointestinal problems including fistula and abscess.
• Chronic, uncontrolled hypertension.
• Patients with any history of primary or metastatic tumor involvement of the brain or with tumors that encase great vessels.

Where it is running

• Scottsdale Medical Imaging, Ltd. — Scottsdale, Arizona, United States
• Premiere Oncology of Arizona — Scottsdale, Arizona, United States
• Premiere Oncology, A Medical Corporation — Santa Monica, California, United States
• Fox Chase Cancer Center — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.